C, C., S, K., DJ, P., & CM, S. (2020). Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions. Frontiers in immunology, 11, 501. https://doi.org/10.3389/fimmu.2020.00501
Chicago Style (17th ed.) CitationC, Caraccio, Krishna S, Phillips DJ, and Schürch CM. "Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions." Frontiers in Immunology 11 (2020): 501. https://doi.org/10.3389/fimmu.2020.00501.
MLA (9th ed.) CitationC, Caraccio, et al. "Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions." Frontiers in Immunology, vol. 11, 2020, p. 501, https://doi.org/10.3389/fimmu.2020.00501.